PT  - JOURNAL ARTICLE
AU  - West, Howard Jack
AU  - McCleland, Mark
AU  - Cappuzzo, Federico
AU  - Reck, Martin
AU  - Mok, Tony SK
AU  - Jotte, Robert M
AU  - Nishio, Makoto
AU  - Kim, Eugene
AU  - Morris, Stefanie
AU  - Zou, Wei
AU  - Shames, David
AU  - Das Thakur, Meghna
AU  - Shankar, Geetha
AU  - Socinski, Mark A
TI  - Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in <em>KRAS-</em>mutated non-small cell lung cancer with <em>STK11</em>, <em>KEAP1,</em> or <em>TP53</em> comutations: subgroup results from the phase III IMpower150 trial
AID  - 10.1136/jitc-2021-003027
DP  - 2022 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003027
VI  - 10
IP  - 2
4099  - http://jitc.bmj.com/content/10/2/e003027.short
4100  - http://jitc.bmj.com/content/10/2/e003027.full
SO  - J Immunother Cancer2022 Feb 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.